Previous Article | Next Article 
Antimicrob Agents Chemother. 1992 June; 36(6): 1332-1335
Effects of antibiotics and other drugs on toxin production in Clostridium difficile in vitro and in vivo.
M C Barc,
C Depitre,
G Corthier,
A Collignon,
W J Su and
P Bourlioux
Laboratoire de Microbiologie, Faculté de Pharmacie, Centre d'Etudes Pharmaceutiques, Châtenay-Malabry, France.
ABSTRACT
In an attempt to understand more completely why patients treated with phenothiazines (chlorpromazine and cyamemazine), methotrexate, and certain antibiotics such as clindamycin have an increased risk of developing pseudomembranous colitis, the production of toxins A and B by Clostridium difficile in the presence of these drugs was measured in vitro as well as in vivo by using axenic mice. None of the drugs tested increased the production of toxins either in vitro or in vivo.
Antimicrob Agents Chemother. 1992 June; 36(6): 1332-1335
This article has been cited by other articles:
-
Deneve, C., Delomenie, C., Barc, M.-C., Collignon, A., Janoir, C.
(2008). Antibiotics involved in Clostridium difficile-associated disease increase colonization factor gene expression. J Med Microbiol
57: 732-738
[Abstract]
[Full Text]
-
Gerber, M., Walch, C., Loffler, B., Tischendorf, K., Reischl, U., Ackermann, G.
(2008). Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile. J Med Microbiol
57: 776-783
[Abstract]
[Full Text]
-
Drummond, L. J., Smith, D. G.E., Poxton, I. R.
(2003). Effects of sub-MIC concentrations of antibiotics on growth of and toxin production by Clostridium difficile. J Med Microbiol
52: 1033-1038
[Abstract]
[Full Text]
-
Freeman, J., O'Neill, F. J., Wilcox, M. H.
(2003). Effects of cefotaxime and desacetylcefotaxime upon Clostridium difficile proliferation and toxin production in a triple-stage chemostat model of the human gut. J Antimicrob Chemother
52: 96-102
[Abstract]
[Full Text]